NCT03156504 The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. Status COMPLETED Phase PHASE4
NCT03092687 Procedures for Sample Acquisition and Distribution for The Human Brain Collection Core Status TERMINATED Phase N/A
NCT03062150 Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression Status COMPLETED Phase NA
NCT03060967 Assessment of Hedonic and Motivational States in Major Depression ( MOODDIS) Status WITHDRAWN Phase NA
NCT03043833 Internet-Delivered Cognitive Behavior Therapy for Anxiety and Depression Amongst French Canadians Status COMPLETED Phase NA
NCT03039387 Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients Status UNKNOWN Phase NA
NCT03005574 Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW Program Status COMPLETED Phase NA
NCT03000530 A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT02998580 Conventional Bilateral rTMS vs. Bilateral Theta Burst Stimulation for Late-Life Depression Status COMPLETED Phase NA
NCT02969876 Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine Status TERMINATED Phase PHASE4
NCT02931487 Restoring Emotion Regulation Networks in Depression Vulnerability Status COMPLETED Phase NA
NCT02916238 Measurement-based Care for Depression in Resource-Poor Settings Status COMPLETED Phase PHASE4
NCT02914769 Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression Status COMPLETED Phase PHASE1/PHASE2
NCT02891564 ESTIA: Computerized Intervention Targeting Cognitive Control Deficits in Depressed Adults Status COMPLETED Phase NA
NCT02890212 Selenium as Augmentation Treatment for Sertraline Resistant Major Depression Status SUSPENDED Phase NA